These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11803162)

  • 21. Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6?
    Stenvinkel P; Barany P; Heimbürger O; Pecoits-Filho R; Lindholm B
    Kidney Int Suppl; 2002 May; (80):103-8. PubMed ID: 11982823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation, malnutrition and atherosclerosis in end-stage renal disease: a global perspective.
    Nascimento MM; Pecoits-Filho R; Lindholm B; Riella MC; Stenvinkel P
    Blood Purif; 2002; 20(5):454-8. PubMed ID: 12207091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy].
    Cases A; Vera M; López Gómez JM
    Nefrologia; 2002; 22 Suppl 1():68-74. PubMed ID: 11987673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory and atherosclerotic interactions in the depleted uremic patient.
    Stenvinkel P
    Blood Purif; 2001; 19(1):53-61. PubMed ID: 11114578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients.
    Hassan KS; Hassan SK; Hijazi EG; Khazim KO
    Ren Fail; 2010; 32(9):1031-5. PubMed ID: 20863205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin.
    Stenvinkel P; Wang K; Qureshi AR; Axelsson J; Pecoits-Filho R; Gao P; Barany P; Lindholm B; Jogestrand T; Heimbürger O; Holmes C; Schalling M; Nordfors L
    Kidney Int; 2005 Jun; 67(6):2383-92. PubMed ID: 15882283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peritoneal dialysis and cardiovascular disease.
    Balafa O; Krediet RT
    Minerva Urol Nefrol; 2012 Sep; 64(3):153-62. PubMed ID: 22971680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of C-reactive protein for heart disease in dialysis patients.
    Wang AY
    Curr Opin Investig Drugs; 2005 Sep; 6(9):879-86. PubMed ID: 16187687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
    Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
    Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of periodontal disease in the kidney patient.
    Craig RG; Spittle MA; Levin NW
    Blood Purif; 2002; 20(1):113-9. PubMed ID: 11803168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-reactive protein as a marker of chronic inflammation in uremic patients.
    Panichi V; Migliori M; De Pietro S; Taccola D; Bianchi AM; Norpoth M; Giovannini L; Palla R; Tetta C
    Blood Purif; 2000; 18(3):183-90. PubMed ID: 10859421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
    J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of malnutrition-inflammation score, dialysis-malnutrition score and serum albumin with novel risk factors for cardiovascular diseases in hemodialysis patients.
    As'habi A; Tabibi H; Hedayati M; Mahdavi-Mazdeh M; Nozary-Heshmati B
    Ren Fail; 2015 Feb; 37(1):113-6. PubMed ID: 25296104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences.
    Yao Q; Axelsson J; Heimburger O; Stenvinkel P; Lindholm B
    Minerva Urol Nefrol; 2004 Sep; 56(3):237-48. PubMed ID: 15467502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?
    Arici M; Walls J
    Kidney Int; 2001 Feb; 59(2):407-14. PubMed ID: 11168922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients.
    Terrier N; Senécal L; Dupuy AM; Jaussent I; Delcourt C; Leray H; Rafaelsen S; Bosc JY; Maurice F; Canaud B; Cristol JP
    Hemodial Int; 2005 Apr; 9(2):159-68. PubMed ID: 16191065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation in end-stage renal disease--a fire that burns within.
    Stenvinkel P
    Contrib Nephrol; 2005; 149():185-199. PubMed ID: 15876843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inflammatory markers, nutritional parameters and polyunsaturated fatty acids in hemodialysis patients].
    Perunicić-Peković GB; Pljesa SI; Rasić ZR; Stanković SD; Ilić MN
    Med Pregl; 2007; 60 Suppl 2():43-7. PubMed ID: 18928156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The predictive value of C-reactive protein in end-stage renal disease: is it clinically significant?
    van der Sande FM; Kooman JP; Leunissen KM
    Blood Purif; 2006; 24(4):335-41. PubMed ID: 16557022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hyperhomocysteinemia, oxidative stress and microinflammation in chronic renal failure: their roles in atherogene].
    Yu YM; Hou FF; Zhang X; Zhou H; Liu ZQ
    Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):292-5. PubMed ID: 15130417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.